Tirzepatide B12 is initiated at a low dose to minimize gastrointestinal side effects, with gradual increases over time based on tolerance and response
Nausea In severe cases of costochondritis, the pain and discomfort can lead to nausea
Liposomal technology encapsulates nutrients in phospholipids, helping protect them from degradation during digestion
Individuals with a history of certain thyroid cancers or pancreatitis may not qualify
Nausea was mentioned by 36.9% of users who described a side effect, followed by fatigue at 16.7%, vomiting at 16.3%, constipation at 15.3%, and diarrhea at 12.6%
Available from Accessed 29 Jul 2022 Chan JCN, Lim LL, Wareham NJ et al (2021) The Lancet Commission on diabetes: using data to transform diabetes care and patient lives